SFM
PRME icon

Sphera Funds Management’s Prime Medicine PRME Stock Holding History

Sphera Funds Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-76,456
Closed -$296K – 125
2024
Q3 		$296K Sell
76,456
-50,968
-40% -$236K 0.05% 110
2024
Q2 		$655K Sell
127,424
-77,818
-38% -$472K 0.09% 111
2024
Q1 		$1.44M Buy
205,242
+131,262
+177% +$995K 0.2% 88
2023
Q4 		$655K Buy
+73,980
New +$570K 0.11% 88

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sphera Funds Management's PRME Position: Q4 2024 in Review

Sphera Funds Management sold out of Prime Medicine (PRME) in Q4 2024, closing a stake of 76,456 shares — an estimated $296K sold.

Sphera Funds Management first reported a position in PRME in Q4 2023 and held it in 4 quarters. The position peaked at $1.44M in Q1 2024. 131 funds tracked by Wall St. Rank hold PRME as of Q4 2024.

  • Sphera Funds Management reported no remaining Prime Medicine position as of Q4 2024 after selling out during the quarter.
  • Sphera Funds Management sold 76,456 Prime Medicine shares in Q4 2024, an estimated $296K.
  • Sphera Funds Management first reported a position in Prime Medicine in Q4 2023 and held it in 4 quarters.
  • Sphera Funds Management's Prime Medicine position peaked at $1.44M in Q1 2024.
  • 131 funds tracked by Wall St. Rank held Prime Medicine as of Q4 2024.

Based on Sphera Funds Management's 13F filing for Q4 2024, filed 14 Feb 2025.